<DOC>
	<DOCNO>NCT02113553</DOCNO>
	<brief_summary>This multicentre , prospective study willing evaluate AMH level change response chemotherapy plus GnRHa . In present study propose determine AMH level breast cancer patient , age &lt; 40yrs receive adjuvant chemotherapy ovarian suppression mean GnRHa aim ass role AMH surrogate marker preservation ovarian reserve exert GnRHa .</brief_summary>
	<brief_title>Anti-Mullerian Hormone ( AMH ) Marker Ovarian Reserve</brief_title>
	<detailed_description>Patients receive 4 8 cycle chemotherapy accord Institutional guideline . Triptorelin 3.75 administer intramuscular injection chemotherapy every 28 day thereafter duration chemotherapy patient ER negative tumor 2 5 year patient ER positive tumor accord Institutional guideline . Patients ER+ve tumour receive tamoxifen 5 year end chemotherapy standard care . A blood sample drawn sign informed consent determine baseline AMH level . A blood sample determination AMH level collect end chemotherapy 12 month end chemotherapy .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Triptorelin Pamoate</mesh_term>
	<criteria>1 . Female subject , age &lt; 40yr time breast cancer diagnosis 2 . Diagnosis operable breast cancer T N , ER 3 . Patients candidate adjuvant chemotherapy 48 cycle . 4 . Patients compliant adhere protocol procedure . 5 . Adequate bone marrow , liver renal function assess follow laboratory requirement conduct within 28 day prior start study treatment . 6 . Negative pregnancy test study enrolment ; fertile woman must use effective contraception chemotherapy 7 . Patients must able understand sign write informed consent . 1 . Presence distant metastasis 2 . Clinically significant cardiovascular disease 3 . Psychological social condition might affect study compliance 4 . Unstable neurologic function 5 . Patients know allergy component study medication 6 . Pregnancy lactation 7 . Any condition , opinion physician likely affect inclusion subject study .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>